Pds Biotechnology Corp Stock Performance
| PDSB Stock | USD 0.71 0.01 0.94% |
The company holds a Beta of 2.03, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, PDS Biotechnology will likely underperform. At this point, PDS Biotechnology Corp has a negative expected return of -0.0636%. Please make sure to check PDS Biotechnology's kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if PDS Biotechnology Corp performance from the past will be repeated at future time.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, PDS Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Last Split Factor 1:20 | Dividend Date 2019-03-18 | Last Split Date 2019-03-18 |
1 | As Legislation Dims Fluorescent Bulbs, Edge LEDs Light Labor Retrofit Panel Offers a 2-Minute LED Fix | 12/02/2025 |
2 | Organized Living Introduces freedomRail EDGE, Its Latest Modular Storage Innovation | 12/08/2025 |
3 | How institutional buying supports PDS Biotechnology Corporation stock - Portfolio Update Report Daily Entry Point Alerts - ulpravda.ru | 01/08/2026 |
4 | Multi-Edge Was Always RightIt Was Just Out Of Reach | 01/14/2026 |
5 | PDS Biotech Announces New U.S. Patent Covering Technology Underlying PDS0101 | 01/22/2026 |
6 | Short Interest in PDS Biotechnology Corporation Increases By 61.8 | 02/02/2026 |
7 | AVIXA Announces InfoComm EDGE in Dubai 2026 A New Experiential AV Showcase | 02/05/2026 |
| Begin Period Cash Flow | 56.6 M | |
| Total Cashflows From Investing Activities | -29 K |
PDS Biotechnology Relative Risk vs. Return Landscape
If you would invest 79.00 in PDS Biotechnology Corp on November 18, 2025 and sell it today you would lose (8.34) from holding PDS Biotechnology Corp or give up 10.56% of portfolio value over 90 days. PDS Biotechnology Corp is currently does not generate positive expected returns and assumes 4.9142% risk (volatility on return distribution) over the 90 days horizon. In different words, 44% of stocks are less volatile than PDS, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
PDS Biotechnology Target Price Odds to finish over Current Price
The tendency of PDS Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.71 | 90 days | 0.71 | more than 93.0 |
Based on a normal probability distribution, the odds of PDS Biotechnology to move above the current price in 90 days from now is more than 93.0 (This PDS Biotechnology Corp probability density function shows the probability of PDS Stock to fall within a particular range of prices over 90 days) .
PDS Biotechnology Price Density |
| Price |
Predictive Modules for PDS Biotechnology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as PDS Biotechnology Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PDS Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PDS Biotechnology Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. PDS Biotechnology is not an exception. The market had few large corrections towards the PDS Biotechnology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold PDS Biotechnology Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of PDS Biotechnology within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.49 | |
β | Beta against Dow Jones | 2.03 | |
σ | Overall volatility | 0.10 | |
Ir | Information ratio | -0.08 |
PDS Biotechnology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of PDS Biotechnology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for PDS Biotechnology Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| PDS Biotechnology generated a negative expected return over the last 90 days | |
| PDS Biotechnology has some characteristics of a very speculative penny stock | |
| PDS Biotechnology has high historical volatility and very poor performance | |
| PDS Biotechnology has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (37.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| PDS Biotechnology Corp currently holds about 52.98 M in cash with (35.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.86, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| PDS Biotechnology has a very weak financial position based on the latest SEC disclosures | |
| Latest headline from prnewswire.com: AVIXA Announces InfoComm EDGE in Dubai 2026 A New Experiential AV Showcase |
PDS Biotechnology Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of PDS Stock often depends not only on the future outlook of the current and potential PDS Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PDS Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 36.5 M | |
| Cash And Short Term Investments | 41.7 M |
PDS Biotechnology Fundamentals Growth
PDS Stock prices reflect investors' perceptions of the future prospects and financial health of PDS Biotechnology, and PDS Biotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PDS Stock performance.
| Return On Equity | -2.22 | ||||
| Return On Asset | -0.46 | ||||
| Current Valuation | 30.12 M | ||||
| Shares Outstanding | 54.72 M | ||||
| Price To Earning | 24.70 X | ||||
| Price To Book | 4.06 X | ||||
| EBITDA | (33.75 M) | ||||
| Net Income | (37.61 M) | ||||
| Cash And Equivalents | 52.98 M | ||||
| Cash Per Share | 1.86 X | ||||
| Total Debt | 21.83 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 12.34 X | ||||
| Book Value Per Share | 0.20 X | ||||
| Cash Flow From Operations | (35.03 M) | ||||
| Earnings Per Share | (0.81) X | ||||
| Market Capitalization | 38.35 M | ||||
| Total Asset | 45.36 M | ||||
| Retained Earnings | (182.11 M) | ||||
| Working Capital | 27.97 M | ||||
| Current Asset | 39.11 M | ||||
| Current Liabilities | 4.54 M | ||||
About PDS Biotechnology Performance
By analyzing PDS Biotechnology's fundamental ratios, stakeholders can gain valuable insights into PDS Biotechnology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if PDS Biotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if PDS Biotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.75) | (0.78) | |
| Return On Capital Employed | (1.48) | (1.40) | |
| Return On Assets | (0.75) | (0.78) | |
| Return On Equity | (2.28) | (2.16) |
Things to note about PDS Biotechnology Corp performance evaluation
Checking the ongoing alerts about PDS Biotechnology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PDS Biotechnology Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PDS Biotechnology generated a negative expected return over the last 90 days | |
| PDS Biotechnology has some characteristics of a very speculative penny stock | |
| PDS Biotechnology has high historical volatility and very poor performance | |
| PDS Biotechnology has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (37.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| PDS Biotechnology Corp currently holds about 52.98 M in cash with (35.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.86, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| PDS Biotechnology has a very weak financial position based on the latest SEC disclosures | |
| Latest headline from prnewswire.com: AVIXA Announces InfoComm EDGE in Dubai 2026 A New Experiential AV Showcase |
- Analyzing PDS Biotechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PDS Biotechnology's stock is overvalued or undervalued compared to its peers.
- Examining PDS Biotechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PDS Biotechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PDS Biotechnology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PDS Biotechnology's stock. These opinions can provide insight into PDS Biotechnology's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for PDS Stock analysis
When running PDS Biotechnology's price analysis, check to measure PDS Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PDS Biotechnology is operating at the current time. Most of PDS Biotechnology's value examination focuses on studying past and present price action to predict the probability of PDS Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PDS Biotechnology's price. Additionally, you may evaluate how the addition of PDS Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |